Principal Investigator
Digestive System Department
Division of General Internal Medicine
更新時間：2023-09-19
- Principal Investigator
- Clinical Trial Experience (year) 22 years 9 個月
Highlights
2. Involved in the Taipei global consensus for gastric cancer prevention (Gut 2020;69:2093-2112)
3. Chair of the Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM)
4. Global leading PI (Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial, clarithromycin, amoxicillin, metronidazole, lansoprazole)
5. Global leading PI (Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial, bismuth (KCB), clarithromycin, amoxicillin, metronidazole, lansoprazole)
Study Area
- Helicobacter pylori infection
- Crohn's Disease
- Ulcerative Colitis
Professional Experiences
Superintendent
-
2020- 迄今
Distinguished Professor
Department of Internal Medicine
Attending Physician
Division of Gastroenterology and Hepatology, Department of Internal Medicine
1995- 迄今
Director
Health Management Center
Vice Director
Office of Research and Development, College of Medicine
Secretary General
-
President
-
Education
Graduate Institute of Clinical Medicine, College of Medicine
Ph.D.
1995-1998
School of Medicine, College of Medicine
M.D.
1982-1989
Clinical Trials List
2016
Total 23
-
I 2
-
I/II 0
-
II 2
-
II/III 1
-
III 18
-
IV 0
-
Others 0
Number of Studies by Scale
1件
Taiwan Multiple Center
Taiwan Single Center
0Cases
Taiwan Multiple Center
1Cases
Multi-Regional Multi-Center
20Cases
